Weight Watchers Reports Mixed Q2 2026 Results Amid Strategic Transition
Event summary
- Total end-of-period subscribers at 2.5 million, with Clinical subscribers up 55.7% year-over-year.
- Core+ Behavioral tier sees third consecutive quarter of sequential growth, up 13.9% year-over-year.
- Revenue reaches $162.3 million, with Clinical Subscription Revenue growing 30.4% year-over-year.
- Company reaffirms full-year 2026 revenue and Adjusted EBITDA guidance.
- Prepaid $36.8 million to reduce outstanding term loan principal.
The big picture
Weight Watchers is navigating a year of focused transition, with Q2 results reflecting early signs of stabilization in its Behavioral business and continued growth in Clinical subscriptions. The company's ability to balance marketing investments while maintaining subscriber retention will be critical as it moves forward. With a cash accretive business model and positive operating cash flow, Weight Watchers aims to build momentum into 2027 amid broader industry trends towards integrated weight management solutions.
What we're watching
- Subscriber Retention
- Whether the company can sustain sequential growth in its Core+ Behavioral tier amid a strategic recalibration of marketing investments.
- Clinical Growth
- The pace at which Clinical Subscription Revenue can continue to grow, especially after lapping significant prior-year growth from the former compounded semaglutide offering.
- Financial Discipline
- How the company's operational discipline and cash-generative nature will support its strategic priorities into 2027 and beyond.